Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Kitov Pharma Ltd. (NASDAQ: KTOV).

Full DD Report for KTOV

You must become a subscriber to view this report.


Recent News from (NASDAQ: KTOV)

Kitov Pharmaceuticals reports 1H results
Kitov Pharmaceuticals (NASDAQ: KTOV ): 1H GAAP EPS of $0.02. More news on: Kitov Pharmaceuticals Holdings Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 29 2018 08:05
Kitov Pharma Provides Corporate Update and Reports First Half 2018 Financial Results
Tel Aviv, Israel, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported financial results for the six months ended June 30, 2018. “The first half of 2018 has been a transforma...
Source: GlobeNewswire
Date: August, 29 2018 08:00
Kitov Announces Settlement of Shareholder Class Action Litigation
Tel Aviv, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV.TA), an innovative biopharmaceutical company, today announced that it has entered into a Stipulation of Settlement with  respect to the shareholder class action lawsuits pending against it i...
Source: GlobeNewswire
Date: July, 30 2018 07:47
Breakfast Technical Briefing on Mirati Therapeutics and Three Other Additional Biotech Stocks
Stock Research Monitor: KTOV, LOXO, and MDGL LONDON, UK / ACCESSWIRE / July 17, 2018/ If you want a free Stock Review on MRTX sign up now at www.wallstequities.com/registration . Today, WallStEquities.com presents for assessment Kitov Pharma Ltd (NASDAQ: KTOV ), Loxo Oncology Inc. (N...
Source: ACCESSWIRE IA
Date: July, 17 2018 07:35
Kitov to Host Business Update Conference Call on Monday, July 2
Tel Aviv, Israel, June 27, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV), an innovative biopharmaceutical company, today announced that it will host a business update conference call on Monday July 2 nd at 8:30 am Eastern Time.  Management will discuss Kitov&#x...
Source: GlobeNewswire
Date: June, 27 2018 09:17

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-170.9550.991.000.95581,967
2018-12-141.060.931.070.8418123,184
2018-12-131.141.04011.14441.02554,602
2018-12-121.101.13041.14211.085341,787
2018-12-111.141.121.16651.1012,301

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-176,99130,51422.9108Cover
2018-12-148,16622,74735.8992Short
2018-12-131,43818,4387.7991Cover
2018-12-124,96811,69342.4870Short
2018-12-112,5546,25440.8379Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on KTOV.


About Kitov Pharma Ltd. (NASDAQ: KTOV)

Logo for Kitov Pharma Ltd. (NASDAQ: KTOV)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: KTOV)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: August, 29 2018
      Notice from the SEC of registration effectiveness
      Filing Type: EFFECTFiling Source: edgar
      Filing Date: August, 08 2018
      Amendment to a previously filed F-3
      Filing Type: F-3/AFiling Source: edgar
      Filing Date: August, 03 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: July, 30 2018
      Registration statement for certain foreign private issuers offered for certain transactions
      Filing Type: F-3Filing Source: edgar
      Filing Date: July, 16 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: June, 27 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: June, 18 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: June, 15 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: June, 11 2018
      Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
      Filing Type: DFiling Source: edgar
      Filing Date: June, 07 2018

       

       


      Daily Technical Chart for (NASDAQ: KTOV)

      Daily Technical Chart for (NASDAQ: KTOV)


      Stay tuned for daily updates and more on (NASDAQ: KTOV)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: KTOV)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in KTOV is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of KTOV and does not buy, sell, or trade any shares of KTOV. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/